DMIIU
Drugs Made In America Acquisition II Corp. Unit • NASDAQ
$10.16 ▲ 0.45% (+0.05)
DMIIU
Drugs Made In America Acquisition II Corp. UnitNASDAQ • $10.16 ▲ 0.45% (+0.05)
Market Cap $706.22 M
52w High $10.80
52w Low $9.94
P/E 0
Volume 300
Outstanding Shares 69.54M
Market Cap $706.22 M
52w High $10.80
52w Low $9.94
P/E 0
Volume 300
Outstanding Shares 69.54M
About Drugs Made In America Acquisition II Corp. Unit
https://dmaacorp.com/A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U.S. reliance on global drug manufacturing. Each unit consists of one ordinary share and one right to receive one-tenth of a share upon completion of a qualifying business combination.
CEO
Roger Bendelac
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Asset Management
Sector Financial Services
Went public September 25, 2025
Method of going public SPAC
Full time employees 2
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0